Third Point CL trades
Daniel Loeb
Daniel Loeb Colgate-Palmolive Company stake
total: 588
Trades details
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2022 Q2
- Held for:
- 4 quarters
- Latest activity:
- 2023 Q2
According to 2026 Q2 report, Daniel Loeb doesn't hold any Colgate-Palmolive Company (CL) shares. To date, the estimated cost basis is nearly $71.95 for "buy" trades and estimated average "sell" price is $75.15. Third Point first purchased CL in 2022 Q2, initially acquiring about 1.98M shares. Since the initial investment in Colgate-Palmolive Company (CL), Third Point has made 3 more transactions.
When did Daniel Loeb sell Colgate-Palmolive Company (CL)?
Daniel Loeb sold off the entire Colgate-Palmolive Company (CL) position in 2023 Q2.
When did Daniel Loeb buy Colgate-Palmolive Company (CL)?
Daniel Loeb first invested in Colgate-Palmolive Company (CL) in 2022 Q2 at the reported quarter-end price of $80.14 per share.
What's the cost basis of Third Point's CL stake?
The estimated cost basis for Colgate-Palmolive Company (CL) stake is around $71.95 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $71.95
- Weighted AVG sell price:
- $75.15
Daniel Loeb's historical trades in Colgate-Palmolive Company
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.00%
|
0
|
$75.15
|
|
-100% (-11,050,000)
|
-13.59%
|
|
2023 Q1
|
13.59%
|
11,050,000
|
$75.15
|
$830,407,500
|
-4.33% (-500,000)
|
-0.63%
|
|
2022 Q3
|
14.66%
|
11,550,000
|
$70.25
|
$811,388,000
|
+481.86% (+9,565,000)
|
+12.14%
|
|
2022 Q2
|
3.77%
|
1,985,000
|
$80.14
|
$159,078,000
|
new
|
+3.77%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.